Breaking News

Maravai LifeSciences to Acquire DNA & RNA Business of Officinae Bio

Will expand Maravai and TriLink BioTechnologies' ability to assist customers in developing innovative nucleic acid-based therapies.

Author Image

By: Charlie Sternberg

Associate Editor

Maravai LifeSciences Inc., a global provider of life science reagents and services to researchers and biotech innovators, has signed an agreement to acquire the DNA and RNA business of Officinae Bio.   The acquisition is expected to expand Maravai and TriLink BioTechnologies’ ability to assist customers in developing innovative nucleic acid-based therapies.   Officinae Bio, based in Venice, Italy, is a private technology company with a digital platform for designing therapeutics. This ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters